Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Quadrivalent inactivated influenza vaccine (IIV)
Locations
1
United States
Stanford University Medical Center, Lane building L134
Stanford, California, United States
Start Date
April 11, 2019
Primary Completion Date
November 17, 2023
Completion Date
November 17, 2023
Last Updated
November 21, 2023
NCT07291635
NCT06094010
NCT06417762
NCT06160128
NCT07396428
NCT07310472
Lead Sponsor
Stanford University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions